CytomX Therapeutics, Inc.
43 SEC EDGAR filings indexed (CIK 0001501989) across 12 form types.
Filing profile
CytomX Therapeutics, Inc. (CTMX) has 43 SEC filings indexed on SecFilingDex, across 12 form types filed over roughly 2 years, from May 13, 2024 to August 6, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 29 of these filings were disclosed in the twelve months to August 6, 2026. 5 of the 43 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 710-QQuarterly report · quarterly
- 4SC 13G/A5%+ passive stake · event-driven
- 3Form 3Initial insider ownership · within 10 days of becoming an insider
- 3424B5Prospectus supplement · event-driven
- 2DEF 14AProxy statement · annual (pre-meeting)
- 2DEFA14ASEC filing
- 210-KAnnual report · annual
- 2SC 13G5%+ passive stake · event-driven
- 1PRE 14ASEC filing
- 1Form 4/AInsider transaction · within 2 business days of transaction
Profile derived from 43 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-337950
- 8-KMaterial event · period of report Aug 6, 2026Filed · 0001193125-26-338009
- Form 3Initial insider ownership · period of report Aug 3, 2026Filed · 0001610717-26-000350
- Form 4Insider transaction · period of report Aug 3, 2026Filed · 0001610717-26-000351
- Form 3Initial insider ownership · period of report Jul 24, 2026Filed · 0001610717-26-000344
- Form 4Insider transaction · period of report Jul 24, 2026Filed · 0001610717-26-000345
- 8-KMaterial event · period of report Jul 24, 2026Filed · 0001193125-26-316929
- 8-KMaterial event · period of report Jun 17, 2026Filed · 0001193125-26-277631
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000275
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000276
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000277
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000278
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000279
- Form 4Insider transaction · period of report Jun 17, 2026Filed · 0001610717-26-000280
- 8-KMaterial event · period of report May 29, 2026Filed · 0001193125-26-255467
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001193125-26-211868
- 8-KMaterial event · period of report May 7, 2026Filed · 0001193125-26-211920
- DEF 14AProxy statementFiled · 0001140361-26-018237
- DEFA14ASEC filingFiled · 0001140361-26-018248
- PRE 14ASEC filing · period of report Jun 17, 2026Filed · 0001140361-26-015658
- 8-KMaterial event · period of report Mar 17, 2026Filed · 0001193125-26-115958
- 424B5Prospectus supplementFiled · 0001193125-26-113931
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-107146
- 8-KMaterial event · period of report Mar 16, 2026Filed · 0001193125-26-107152
- 424B5Prospectus supplementFiled · 0001193125-26-108461
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001193125-25-269477
- 8-KMaterial event · period of report Nov 6, 2025Filed · 0001193125-25-269533
- Form 3Initial insider ownership · period of report Oct 20, 2025Filed · 0001610717-25-000369
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0000950170-25-104991
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0000950170-25-068511
- 424B5Prospectus supplementFiled · 0001193125-25-117880
- DEF 14AProxy statement · period of report Jun 11, 2025Filed · 0001140361-25-016026
- DEFA14ASEC filingFiled · 0001140361-25-016028
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0000950170-25-034575
- Form 4/AInsider transaction · period of report Feb 4, 2025Filed · 0001610717-25-000020
- SC 13G/A5%+ passive stakeFiled · 0000921895-24-002717
- SC 13G/A5%+ passive stakeFiled · 0001172661-24-005044
- SC 13G/A5%+ passive stakeFiled · 0001214659-24-019106
- SC 13G/A5%+ passive stakeFiled · 0001274173-24-000114
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0000950170-24-123249
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0000950170-24-093865
- SC 13G5%+ passive stakeFiled · 0001274173-24-000069
- SC 13G5%+ passive stakeFiled · 0000929638-24-001775
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.